FNDC5 and breast carcinoma: Studies performed by Provatopoulou et al. (2015) demonstrated that serum irisin levels are significantly reduced in breast cancer patients compared with those in controls, and one unit increase in irisin levels leads to a reduction in the probability of breast cancer by approximately 90%.